Active Research Studies
Active research studies
At GMMH, we want to provide opportunities for our service users and staff to take part in research.
We have a wide range of studies covering mental health, dementia and health services. We have a study to suit every service user.
Our studies range from questionnaires and observational studies, to clinical and drug trials. Participation can last from as little as 15 minutes to several years.
Many of our studies are high-quality research studies included in the National Institute for Health and Care Research (NIHR) Clinical Research Network (CRN) portfolio.
If you are interested or know somebody who is interested in taking part in any of the studies below, please email askaboutresearch@gmmh.nhs.uk
GMMH Active R&I Studies
Study Title | Description | Study Contact | Current PIS (Participant Information Sheet) | Web Link |
---|---|---|---|---|
Prevention of suicide behaviour in prison (work packages 3 and 4) |
The prevention of suicide behaviour in prison: enhancing access to therapy (PROSPECT) programme (work packages 3 and 4) Chief Investigator: Daniel Pratt |
Jessica McGiffen |
PIS Prospect Process Evaluation - Prospect Practitioner Version v2.pdf [pdf] 248KB PIS Prospect Process Evaluation Interviews - Service user v2.pdf [pdf] 245KB PIS Prospect Process Evaluation Interviews - Service user v2.pdf [pdf] 245KB PIS Prospect Process Evaluation Interviews - Staff Version v2.pdf [pdf] 247KB PIS Prospect Process Evaluation Observation study - Service User Version v2.pdf [pdf] 244KB |
|
Relational Approach to Treating Self-Harm (RelATe) |
Relational Approach to Treating Self-Harm (RelATe): A Feasibility Study of Cognitive Analytic Therapy for People who Self-Harm Chief Investigator: Peter Taylor |
Jessica McGiffen | RELATE PIS.pdf [pdf] 294KB | |
Bipolar At Risk Trial II (BART II) |
Cognitive behavioural therapy in comparison to treatment as usual in young adults at high risk of developing bipolar disorder (Bipolar At Risk): A randomised controlled trial to investigate the efficacy of a treatment approach targeted at key appraisal change Chief Investigator: Sophie Parker |
Momina Moughal | BART II PIS.pdf [pdf] 228KB | |
ADEPP |
Antidepressant for the prevention of DEPression following first episode Psychosis trial Chief Investigator: Rachel Upthegrove |
Naomi Berry | ||
Pharmacogenetics in mental health |
Personalised medicine for psychotropic drugs (antipsychotics, antidepressants, antimanic agents and other pychotropics) Chief Investigator: Elvira Bramon |
Pharmacogenetics in mental health - Localised_Participant Information Sheet_V1.6_15Sep22.pdf [pdf] 167KB | ||
Care Coordinator Delivered Method of Levels for Psychosis (CAMEO) |
Improving engagement and recovery in people with early psychosis through Method of Levels therapy delivered by care coordinators: Feasibility cluster randomised controlled trial Chief Investigator: Robert Griffiths |
Momina Moughal |
CAMEO - PIS care coordinator version 1.1_13.04.2022.pdf [pdf] 267KB CAMEO - PIS service user version 1.1_13.04.2022.pdf [pdf] 306KB |
|
Testing the Smoke Free app in Early Intervention Services |
Using smartphone apps for smoking cessation in first-episode psychosis: A feasibility study Chief Investigator: Joseph Firth |
Steve Lankshear | Testing the Smoke Free app in Early Intervention Services - PIS_V9 16-12-21.pdf [pdf] 357KB | |
Prevalence of pathogenic antibodies in psychosis (PPiP2) |
Prevalence of neuronal cell surface antibodies in patients with psychotic illness Chief Investigator: Belinda Lennox |
Steve Lankshear | CLICK HERE | |
Genetic Links to Anxiety and Depression (GLAD) |
NIHR Mental Health BioResource for Depression and Anxiety Chief Investigator: Gerome Breen |
Carmel Thomas | GLAD - PIS.pdf [pdf] 209KB | CLICK HERE |
Family Intervention for Africans and Caribbeans with Psychosis Trial (CaFI-2 RCT) |
The effect on relapse of Culturally-adapted Family Intervention (CaFI) compared to usual care among African & Caribbean people diagnosed with psychosis in the UK: a Randomised Controlled Trial Chief Investigator: Dawn Edge |
Momina Moughal |
CaFI - PIS and ICF Care Coordinators.pdf [pdf] 358KB CaFI - PIS and ICF Therapists.pdf [pdf] 385KB CaFI - PIS_Under 16s_Service Users.pdf [pdf] 289KB CaFI - PIS Family Support Members (Over 16s).pdf [pdf] 380KB CaFI - PIS Under 16s_Relatives and Carers.pdf [pdf] 314KB |
CLICK HERE |
IPPACT Phase 3: Observational Cohort Study - v1 |
Improving prediction of psychosis in ARMS using a clinically useful prognostic tool (IPPACT) - Cohort Study Chief Investigator: Filippo Varese |
Emma de Paolo | IPPACT - PIS.pdf [pdf] 204KB | |
The RESTART Project |
The RESTART Project: A mixed-method study to examine the emotional and psychological impacts of trauma and resolve barriers to trauma therapy in people with an at risk mental state Chief Investigator: Filippo Varese |
Emma DePaola |
RESTART - (Healthcare professionals) Participant information sheet_v1_ 17 06 2021.pdf [pdf] 264KB RESTART - (cohort study) participant information sheet_ v1 17 06 2021.pdf [pdf] 290KB RESTART - (qualitative interview) partcipant information sheet _v1_17 06 2021.pdf [pdf] 274KB |
|
Remote Approaches to Psychosocial Intervention Delivery (RAPID) |
Remote psychosocial interventions to prevent avoidable psychiatric hospital admissions in people with serious mental health problems: a multi-arm multi-stage trial Chief Investigator: Tony Morrison |
RAPID - PIS 3.0 25_05_2022 clean.pdf [pdf] 258KB | ||
Access Assessments for Admission to Adult Medium & Low Secure Services |
Access Assessments for Admission to Adult Medium & Low Secure Services Chief Investigator: Sarah Leonard |
Kelly Gallagher | Access Assessments for Admission to Adult Medium & Low Secure Services - PIS.pdf [pdf] 152KB | |
Lumi Nova: Implementation in Greater Manchester |
Lumi Nova - a digital intervention supporting 7-12 year olds who experience symptoms of anxiety. An implementation study in Greater Manchester to optimise for economically disadvantaged children. Chief Investigator: Pauline Whelan |
Donna Watterson |
Lumi Nova - PIS 7-12 V3.0 22.07.22.pdf [pdf] 385KB Lumi Nova - PIS PG of CYP ppts V3.0 22.07.22.pdf [pdf] 609KB |
|
Service user & staff views on digital remote monitoring for psychosis (CONNECT) |
A qualitative study of service user and staff views on digital remote monitoring for unusual distressing experiences (psychosis) Chief Investigator: Sandra Bucci |
Steve Lankshear | ||
Stratification of sporadic Alzheimer’s disease for drug discovery II (StrataStem) |
Stratification of sporadic Alzheimers disease for an intelligent drug discovery approach using patient derived induced pluripotent stem cells: Improving therapeutic intervention, diagnosis and prognosis of sporadic Alzheimer's disease using in vitro neuronal models of the disease. Chief Investigator: Chris Ward |
Leanne Howieson | StrataStem - PIS.pdf [pdf] 185KB | |
A study of AVP-786 for agitation in patients with Alzheimer's dementia |
A Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of agitation in patients with dementia of the Alzheimer's type Chief Investigator: Salman Karim |
Leanne Howieson | ||
Avoidable harm in prison healthcare |
Understanding the scale and nature of avoidable harm in prison healthcare Chief Investigator: Jennifer Shaw |
Anita Davies |
Avoidable Harm in Prison - PIS (Family) v2.pdf [pdf] 191KB |